BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 37313409)

  • 21. Integrative analysis of cancer-associated fibroblast signature in gastric cancer.
    Zhao Z; Mak TK; Shi Y; Li K; Huo M; Zhang C
    Heliyon; 2023 Sep; 9(9):e19217. PubMed ID: 37809716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
    Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
    Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of cancer-associated fibroblasts in esophageal squamous cell carcinoma.
    Ha SY; Yeo SY; Xuan YH; Kim SH
    PLoS One; 2014; 9(6):e99955. PubMed ID: 24945657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
    Guo J; Tong C; Shi J; Li X; Chen X
    Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
    Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
    Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma.
    Li S; Liu Z; Chen Q; Chen Y; Ji S
    Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
    Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
    Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma.
    Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW
    Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods.
    Sun Q; Zong L; Zhang H; Deng Y; Zhang C; Zhang L
    Mol Med Rep; 2018 Apr; 17(4):5222-5228. PubMed ID: 29393486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.
    Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H
    Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S
    Front Immunol; 2022; 13():918154. PubMed ID: 35880180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.
    Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY
    BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.
    Zhang Y; Chen K; Wang L; Chen J; Lin Z; Chen Y; Chen J; Lin Y; Xu Y; Peng H
    Aging (Albany NY); 2023 Sep; 15(17):8993-9021. PubMed ID: 37665670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma.
    Zheng B; Li J; Zhang M; Zhang P; Deng W; Pu Y
    Front Immunol; 2023; 14():1117658. PubMed ID: 36817484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.